UNM enters its April 29 Q1 results with options positioning unusually tilted toward calls — a contrast to the muted analyst sentiment and a cluster of insider selling that preceded the report.
The options market is the clearest outlier heading in. The put/call ratio has dropped to 0.23, well below its 20-day average of 0.37 and close to the annual low of 0.16. That is more than one standard deviation beneath the recent mean, pointing to a market that has been building call exposure rather than buying downside protection. Short interest reinforces the lack of bearish conviction: SI % of float has fallen around 12% over the past month to roughly 1.9% of the free float, a level that carries little short-squeeze relevance. Borrow conditions are equally relaxed — cost to borrow is 0.40%, and availability is extremely loose, meaning the lending market is offering no signal of fresh short positioning ahead of the event.
The analyst community is less aligned with that optimism. The Street has broadly been trimming targets since early February, with B of A Securities cutting to $77 on April 14 — essentially the current price — while maintaining a Neutral rating, and Morgan Stanley lowering to $80 in early March. Wells Fargo has stayed Overweight but nudged its target down twice, arriving at $99. KBW reinstated with an Outperform in late March at $95. The mean target of $93 implies about 20% upside from the current $77.82, but the recent direction of travel has been downward revisions. The bull case rests on high-return-on-equity group benefits, strong free cash flow conversion, and a favorable interest rate environment. Bears point to rising group disability benefit ratios projected at 62–63%, the prospect of GAAP assumption reviews in long-term care, and slipping EPS estimates for 2025 and 2026. A 90-day forward EPS growth rank of 79th percentile offers some fundamental support for the bulls, but 90-day EPS momentum sits in just the 12th percentile — the near-term revision trend has been negative.
Insider activity over recent months tilts one-sided toward selling. The CFO sold shares in late February, joined by several executive vice presidents on the same date. A further sale came from the General Counsel in March. None of the trades are individually large, and all came at prices around $71–73 — below the current level — but the pattern of broad-based executive selling in the weeks before an earnings print is worth noting as context. The stock has since recovered, up 6.7% over the past month to $77.82, though it dipped 1.2% on the week. After the February 2026 Q4 print, UNM fell 5.2% on the day and extended losses to roughly 5.3% over the following five trading sessions — the most recent data point the market has for how the stock behaves after a quarterly report.
The print will therefore test whether the company can demonstrate that disability claims pressure is stabilizing and that the forward earnings trajectory justifies a re-rating back toward the $93 consensus target — or whether the recent analyst caution and insider selling ahead of the release captured something the options buyers have chosen to overlook.
See the live data behind this article on ORTEX.
Open UNM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
